Thank you, you are now logged in. x
Multivascular PCI may be the way to go in STEMI

Multivascular PCI may be the way to go in STEMI

Finding could change current practice if backed up with further randomised trials

Ezetimibe data confirms CHD benefits for high-risk patients

Ezetimibe data confirms CHD benefits for high-risk patients

The medication cuts risk of coronary events when prescribed in combination with statin therapy

$82 million boost for cardio research

$82 million boost for cardio research

Over 100 heart-related projects get a slice of the NHMRC pie

Study highlights beta-blocker misunderstanding

Study highlights beta-blocker misunderstanding

Unnecessarily high doses may cause significant morbidity without increasing benefits

VTE rates jump in NSW hospitals

VTE rates jump in NSW hospitals

Researchers call for new preventive strategies to combat the problem

Latest News

Aussies out and about at AHA 2014

Aussies out and about at AHA 2014

0

Managing atrial fibrillation, NOACs and alirocumab efficacy are among the topics covered in presentations by Australian researchers

view more

Opinion

WCC blog: secondary prevention is the low hanging fruit

One of the most interesting presentations at the World Congress of Cardiology in Melbourne this week was a talk by Professor Philip Aylward of Adelaide on how far we have come in the treatment of ACS.

CSANZ 2013 blog: For the ticker, timing is everything

While it’s great to attend a conference like CSANZ, the sheer amount of new and interesting information can be almost too much of a good thing.

view more

Cardiology Update on Twitter

­
Advertisement
Advertisement
Advertisement